This company listing is no longer active
Probi (PROB) Stock Overview
Researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PROB Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Probi AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 348.00 |
| 52 Week High | SEK 352.00 |
| 52 Week Low | SEK 197.00 |
| Beta | 0.44 |
| 1 Month Change | 0% |
| 3 Month Change | 32.82% |
| 1 Year Change | 65.71% |
| 3 Year Change | -5.56% |
| 5 Year Change | 42.33% |
| Change since IPO | 873.43% |
Recent News & Updates
Recent updates
Probi AB (publ)'s (STO:PROB) Price Is Right But Growth Is Lacking After Shares Rocket 31%
Nov 21
Probi's (STO:PROB) Anemic Earnings Might Be Worse Than You Think
Jul 24There's No Escaping Probi AB (publ)'s (STO:PROB) Muted Revenues Despite A 43% Share Price Rise
Jun 26Should You Be Adding Probi (STO:PROB) To Your Watchlist Today?
Sep 08Estimating The Intrinsic Value Of Probi AB (publ) (STO:PROB)
Aug 12Is Now The Time To Put Probi (STO:PROB) On Your Watchlist?
May 26Probi AB (publ)'s (STO:PROB) Intrinsic Value Is Potentially 19% Below Its Share Price
May 05Is Probi AB (publ)'s (STO:PROB) Recent Price Movement Underpinned By Its Weak Fundamentals?
Mar 05Here's Why I Think Probi (STO:PROB) Might Deserve Your Attention Today
Feb 15Here's What Probi AB (publ)'s (STO:PROB) Shareholder Ownership Structure Looks Like
Jan 29
Probi AB (publ)'s (STO:PROB) Intrinsic Value Is Potentially 20% Below Its Share Price
Jan 11Shareholder Returns
| PROB | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | -0.6% | 0.8% | 1.4% |
| 1Y | 65.7% | -1.2% | 8.3% |
Return vs Industry: PROB exceeded the Swedish Biotechs industry which returned 15.6% over the past year.
Return vs Market: PROB exceeded the Swedish Market which returned 13.7% over the past year.
Price Volatility
| PROB volatility | |
|---|---|
| PROB Average Weekly Movement | 12.7% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in SE Market | 11.5% |
| 10% least volatile stocks in SE Market | 2.9% |
Stable Share Price: PROB's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: PROB's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 157 | Anita Johansen | www.probi.com |
Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. The company conducts research primarily in the fields of mental, digestive, immune, bone, oral, children’s, women’s, and senior health, as well as iron absorption. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, chilled diary and plant based products, frozen desserts and ice-cream, powder formulas, and recovery drinks.
Probi AB (publ) Fundamentals Summary
| PROB fundamental statistics | |
|---|---|
| Market cap | SEK 3.97b |
| Earnings (TTM) | SEK 10.88m |
| Revenue (TTM) | SEK 630.39m |
Is PROB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PROB income statement (TTM) | |
|---|---|
| Revenue | SEK 630.39m |
| Cost of Revenue | SEK 421.23m |
| Gross Profit | SEK 209.16m |
| Other Expenses | SEK 198.27m |
| Earnings | SEK 10.88m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 28, 2025
| Earnings per share (EPS) | 0.96 |
| Gross Margin | 33.18% |
| Net Profit Margin | 1.73% |
| Debt/Equity Ratio | 0% |
How did PROB perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/14 22:45 |
| End of Day Share Price | 2025/02/12 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Probi AB (publ) is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jakob Lembke | ABG Sundal Collier Sponsored |
| null null | ABG Sundal Collier Sponsored |